Clinical pharmacokinetics of imatinib mesylate

In Vivo. 2005 Jan-Feb;19(1):77-84.

Abstract

This review presents the clinical pharmacokinetics of imatinib mesylate. Aspects regarding absorption, tissue distribution, elimination and kinetic interactions are also discussed.

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacokinetics*
  • Benzamides
  • Drug Interactions
  • Enzyme Inhibitors / therapeutic use*
  • Gastrointestinal Neoplasms / drug therapy*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Piperazines / administration & dosage
  • Piperazines / pharmacokinetics*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Pyrimidines / administration & dosage
  • Pyrimidines / pharmacokinetics*
  • Stromal Cells / drug effects

Substances

  • Antineoplastic Agents
  • Benzamides
  • Enzyme Inhibitors
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases